Hyperfine, Inc. (HYPR) stock
HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3028% below fair value
$0.54−0.02 (-2.97%)
Close on Nov 18, 2026Market cap $57.79MP/E –Yield –
Hyperfine revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Hyperfine's revenue for the twelve months ending Jun 30, 2026 was $16.54M, up 53.2% year over year. For fiscal 2025 it was $13.56M, up 5.2% from the year before. The highest annual figure on record is $13.56M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.56M | +5.2% |
| FY2024 | Dec 31, 2024 | $12.89M | +16.8% |
| FY2023 | Dec 31, 2023 | $11.03M | +61.9% |
| FY2022 | Dec 31, 2022 | $6.81M | +355.5% |
| FY2021 | Dec 31, 2021 | $1.50M | +408.8% |
| FY2020 | Dec 31, 2020 | $294.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.90M | +44.8% |
| Q1 FY2026 | Mar 31, 2026 | $3.90M | +82.6% |
| Q4 FY2025 | Dec 31, 2025 | $5.29M | +128.0% |
| Q3 FY2025 | Sep 30, 2025 | $3.44M | -5.7% |
| Q2 FY2025 | Jun 30, 2025 | $2.70M | -25.8% |
| Q1 FY2025 | Mar 31, 2025 | $2.14M | -35.1% |
| Q4 FY2024 | Dec 31, 2024 | $2.32M | -13.6% |
| Q3 FY2024 | Sep 30, 2024 | $3.64M | +56.4% |
| Q2 FY2024 | Jun 30, 2024 | $3.63M | +7.4% |
| Q1 FY2024 | Mar 31, 2024 | $3.30M | +25.0% |
| Q4 FY2023 | Dec 31, 2023 | $2.69M | +88.6% |
| Q3 FY2023 | Sep 30, 2023 | $2.33M | -0.8% |
| Q2 FY2023 | Jun 30, 2023 | $3.38M | +120.5% |
| Q1 FY2023 | Mar 31, 2023 | $2.64M | +74.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.42M | +226.6% |
| Q3 FY2022 | Sep 30, 2022 | $2.35M | +532.9% |
| Q2 FY2022 | Jun 30, 2022 | $1.53M | +328.2% |
| Q1 FY2022 | Mar 31, 2022 | $1.51M | +355.9% |
| Q4 FY2021 | Dec 31, 2021 | $436.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $371.00K | – |
| Q2 FY2021 | Jun 30, 2021 | $358.00K | – |
| Q1 FY2021 | Mar 31, 2021 | $331.00K | – |
See a number that looks wrong?